What obesity drugmakers see next in the market: More pills, easier access and drug combinations by CNBC Markets | January 23, 2026 6:20 pm | US Markets CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
